Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 7:24 PM
Ignite Modification Date:
2025-12-24 @ 7:24 PM
NCT ID:
NCT00003903
Eligibility Criteria:
DISEASE CHARACTERISTICS:
* Histologically confirmed prostate cancer
* Stratum 1 (androgen ablation therapy):
* Bone metastases
* Prior orchiectomy allowed
* Prior or concurrent leuprolide and/or goserelin therapy allowed
* Stratum 2 (androgen ablation therapy):
* No bone metastases
* Prior orchiectomy allowed
* Prior or concurrent leuprolide and/or goserelin therapy allowed
* Stratum 3 (no androgen ablation therapy):
* No metastatic disease
* Prior flutamide or bicalutamide therapy allowed
PATIENT CHARACTERISTICS:
Age:
* Not specified
Performance status:
* Not specified
Life expectancy:
* Not specified
Hematopoietic:
* Calcium normal
Hepatic:
* Not specified
Renal:
* Not specified
PRIOR CONCURRENT THERAPY:
Biologic therapy:
* Not specified
Chemotherapy:
* See Disease Characteristics
Endocrine therapy:
* See Disease Characteristics
* No concurrent high dose steroids
Radiotherapy:
* Prior radiotherapy allowed
Surgery:
* See Disease Characteristics
* Prior radical prostatectomy allowed
Other:
* No concurrent bisphosphonates
Healthy Volunteers:
False
Sex:
MALE
Study:
NCT00003903
Study Brief:
Protocol Section:
NCT00003903